Zobrazeno 1 - 10
of 131
pro vyhledávání: '"De-Zai Dai"'
Autor:
De-Zai Dai, Yin Dai
Publikováno v:
Vascular Health and Risk Management, Vol 2010, Iss default, Pp 787-794 (2010)
De-Zai Dai, Yin DaiResearch Division of Pharmacology, China Pharmaceutical University, Nanjing, 210009, ChinaAbstract: Vascular dilatation is critically impaired in many diseases and is encountered by an upregulated endothelin receptor A (ETA) in the
Externí odkaz:
https://doaj.org/article/84064e6c896a4d788d3c4e3cafb43540
Autor:
De-Zai Dai, Qing Li, Xiao-dong Cong, Ming Xu, Hussein-hamed Khan, Fang-hong Shi, Yin Dai, Chen Hu
Publikováno v:
Acta Pharmacologica Sinica. 37:246-254
Argirein (rhein-arginine) is a derivative of rhein isolated from Chinese rhubarb (Rheum Officinale Baill.) that exhibits antioxidant and anti-inflammatory activities. In the present study we investigated the effects of argirein on stress-induced (hyp
Publikováno v:
Journal of Pharmacy and Pharmacology. 67:1029-1041
ObjectivesDeterioration of cardiac performance under stress may be partly mediated by dysfunctional mitochondria and endoplasmic reticulum (ER) that is likely related to an activation of NADPH oxidase (NOX) and an increase in pro-inflammatory factors
Publikováno v:
Clinical and experimental pharmacologyphysiology. 44(11)
Summary Aquaporin 4 (AQP4) is a type of water channel protein that maintains the water balance of cardiomyocytes. However, the physiological role of AQP4 in cardiovascular disease is poorly understood. We wanted to explore whether p66Shc and endoplas
Publikováno v:
Neurochemical Research. 39:719-730
Inflammatory changes in the cerebral network are present in early mechanisms involved in neurodegenerative disease, Alzheimer disease (AD), and aging brain. We intended to verify that these are likely due to an activation of NADPH oxidase (NOX) and e
Publikováno v:
European Journal of Pharmacology. 721:249-258
Aquaporin 4 (AQP4) is essential in normal kidney. We hypothesized that AQP4 knockout (KO) may exacerbate pro-inflammatory factors in the stress induced renal insufficiency. Mechanisms underlying are likely due to activating renal oxidative stress ada
Publikováno v:
Clinical & Experimental Pharmacology & Physiology. Dec2007, Vol. 34 Issue 12, p1228-1233. 6p. 1 Chart, 3 Graphs.
Publikováno v:
Clinical & Experimental Pharmacology & Physiology. Apr2007, Vol. 34 Issue 4, p310-317. 8p. 1 Diagram, 2 Charts, 9 Graphs.
Autor:
De-Zai Dai1 dezaidai@vip.sina.com
Publikováno v:
Cardiovascular Drug Reviews. Summer2006, Vol. 24 Issue 2, p101-115. 15p. 1 Diagram, 1 Chart.
Publikováno v:
Acta Pharmacologica Sinica. 34:1575-1584
Hypoxia/oxidative stress can alter the pharmacokinetics (PK) of CPU86017-RS, a novel antiarrhythmic agent. The aim of this study was to investigate the mechanisms underlying the alteration of PK of CPU86017-RS by hypoxia/oxidative stress. Male SD rat